openPR Logo
Press release

“Diabetic Retinopathy Market” 2018 Witnessed a new Surge In Diabetic Retinopathy Cases worldwide – Insight 2018-2023

08-10-2018 12:31 PM CET | Health & Medicine

Press release from: Market Research Future

diabetic retinopathy

diabetic retinopathy

Eye diseases in diabetic patients are known as "Diabetic Retinopathy". High blood sugar levels lead to the damage of the blood vessels in the retina. This results in the swelling and leakage of blood vessels or the blood vessels may close, thereby stopping blood from passing through. Sometimes, abnormal growth of new blood vessels is found on the retina. Blurred vision, dark or empty areas in your vision, spots or dark strings floating in the vision (floaters), impaired color vision, and vision loss are various symptoms of diabetic retinopathy. Vitreous hemorrhage, retinal detachment, glaucoma, and blindness are various complications associated with diabetic retinopathy, which may further lead to vision loss. The disease can be prevented by managing diabetes, controlling blood glucose levels, attention to vision changes, and many other methods in order to avoid vision impairment or vision loss.

The global diabetic retinopathy market is driven by the increasing prevalence of diabetes, rising awareness about diabetic retinopathy, and availability of treatment in the market. Furthermore, the increasing demand for diagnostic tests for the early diagnosis of diabetic retinopathy drives the growth of the market. However, the growth of the market is restrained by inaccuracy in a diagnostic test and lack of awareness about diagnosis and treatment of the diseases among the geriatric population, especially in developing countries across the globe. Diabetic Retinopathy Market is expected to grow at a CAGR of 5.2% during the forecast period.

Obtain a Sample Report @ https://www.marketresearchfuture.com/sample_request/5792

Global Diabetic Retinopathy Market – Key Players

Novartis AG (Germany), Bayer (Germany), Regeneron Pharmaceuticals Inc. (U.S.), ThromboGenics (U.S.), Actavis Plc (U.K.), Sirnaomics (U.S.), Genentech (U.S.), Alimera Sciences (U.S.), Glycadia Pharmaceuticals (U.S.), Ampio Pharmaceuticals (U.S.), Kowa Group (Japan), BCN Peptides (Spain), and others.

Intended Audience:

• Medical Device Manufacturers
• Medical Device Suppliers
• Medical Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Potential Investors

Global Market Diabetic Retinopathy – Segmentation

The global diabetic retinopathy market is segmented on the basis of type, diagnosis, treatment, indication, and end-user. On the basis of type, the market is segmented into non-proliferative diabetic retinopathy and proliferative advanced diabetic retinopathy. On the basis of diagnosis, the market is segmented into fluorescein angiography and optical coherence tomography. On the basis of treatment, the market is segmented into laser treatment, anti-VEGF Therapy, vitrectomy, and others. The laser treatment is further segmented into focal laser treatment and scatter laser treatment. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, research institutes, and others.

Get Exclusive Discount on Report @ https://www.marketresearchfuture.com/check-discount/5792

Global Diabetic Retinopathy Market – Regional Analysis

The American diabetic retinopathy is the largest across the globe and is driven by the diagnostic imaging and increasing focus on early diagnosis of diseases. The U.S. is the largest market in North America which is driven by the increasing number of diabetic patients becoming aware of the diagnosis and treatment of diabetic retinopathy and the increasing demand for diagnostic tests in hospitals and clinics. Further, people in Americas are now getting aware of the prevention of the disease thereby avoiding further complications. The presence of major players and emphasis on preventive care also stimulate the growth of the market. Canada is expected to be the fastest growing market with the increasing number of diagnostic and treatment services. South America also exhibits tremendous growth opportunities in the market.

The European diabetic retinopathy market is driven by the increasing patient population and availability of treatment options for diabetes. Furthermore, the increasing emphasis on diabetes management and the rising importance of early diagnosis and treatment of the disease among the general population are also expected to fuel the growth of the market during the forecast period. The growth of the market in Germany, the largest contributor to the market growth, is driven by huge investments in research and development on lifestyle diseases such as diabetes, cardiovascular diseases, obesity, and others.

In Asia Pacific, the market growth is boosted by various factors such as high prevalence of chronic diseases such as obesity, diabetes, and others and presence of a huge geriatric population in countries such as China. Furthermore, the diabetic population in China and India has created a demand for diagnosis and treatment of diabetic retinopathy, thereby accelerating the market growth. Other factors affecting the growth of the market in Asia Pacific are lifestyle changes, obesity, and sedentary lifestyle of people.

The market in the Middle East and Africa determines a steady growth with the increasing demand for diabetes management and rising number of diagnostic services. Saudi Arabia and the United Arab Emirates (U.A.E.) are the largest contributors to the growth of the market in the Middle East.

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

TOC Continued….

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/5792

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release “Diabetic Retinopathy Market” 2018 Witnessed a new Surge In Diabetic Retinopathy Cases worldwide – Insight 2018-2023 here

News-ID: 1173108 • Views: 406

More Releases from Market Research Future

Dermal Fillers Market Business Insights & Deep Analysis to 2025 by World’s Top …
Market Scope The global dermal filler market can reach a valuation of USD 6,899.16 million by 2025. It is predicted to expand at a CAGR of 13.2% over the forecast period. Dermal fillers or wrinkle fillers are solutions injected into the skin. Its effects can last from six months to two years. Efforts are being made to prolong its effects and revolutionize anti-aging. The global dermal filler market report by Market Research
Field Programmable Gate Array Market 2021 Size, Share, Industry Analysis, Emergi …
Field Programmable Gate Array Market by technology (EEPROM, Antifuse, SRAM, Flash, and others (EPROM and PROM), by Application (data processing, consumer electronics, industrial, military & aerospace, automotive, telecom, and others), and by Type (high-end, mid-end, and low-end FPGA) - Global Opportunity Analysis and Industry Forecast, 2017-2023 According to a recent report published by Allied Market Research, titled, Field Programmable Gate Array Market by Technology, Application, and Type: Global Opportunity Analysis and
Semiconductor IC Tester Market Growth Factor, Demand, Size, Share, Trends, Growt …
The Semiconductor IC Tester Market research report includes Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the Semiconductor IC Tester market growth. Semiconductor IC Tester is
Tilt Sensor Market Share, COVID-19 Pandemic Impact, Comprehensive Analysis, Oppo …
Global Tilt Sensor Market Highlights: The global Tilt Sensor Market is growing rapidly over 7.42% of CAGR and is expected to reach at USD 257.64 million by the end of forecast period. The global tilt sensor market has been witnessing a steady growth over the last few years on account of rapid growth of automobile and transportation market, high implementation of sensors in the constructions machines and rising demand for tilt

All 5 Releases


More Releases for Diabetic

Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and
Global Diabetic Care Devices Market
The global diabetes monitoring devices market generally consists of the following devices: self-glucose monitoring devices, blood glucose meter devices, blood glucose test strips, lancets and lancet devices, continuous glucose monitoring devices, transmitters and receivers. This report does not include other medical devices used in hospitals. To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=2798595 The scope of the report includes an overview of the global market for diabetes monitoring devices and analyses
Expanding Diabetic Populace Driven Growth For Diabetic Food Market Globally
Market Overview Diabetic Food items are dietary items that incorporate diminished starch and sugar substance that assistance in controlling the ascent of the blood glucose. Diabetic Food additionally contains low calorie sweeteners, slim down refreshments, and so on. These items are devoured by diabetic individuals and by the general population who are not diabetic as careful step to avoid diabetes. Diabetic nourishment makers are entering into different market fragments by presenting
Diabetic Alcohol Swabs Market
An alcohol swab is gauze that has been dipped and saturated with alcohol. It is a vital part of any first aid kit. Alcohol swabs are primarily used to disinfect and clean cuts and scrapes. They are used in doctors’ clinics, diagnostic centers, and other places where quick and easy cleaning of a locale is desired. The alcohol in the alcohol swabs helps get rid of possible sources of contamination
Global Diabetic Retinopathy Market
The Diabetic Retinopathy Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Diabetes is the chronic condition associated with abnormally high level of glucose in the blood. Insufficient or non production of insulin in pancreas causes diabetes. Globally, the incidence of diabetes is
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be